ArticleWorld journal of psychiatry2024

Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia.

Bao-Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.